Segmental expression of somatostatin receptor subtypes sst1 and sst2 in tubules and glomeruli of human kidney

American Journal of Physiology - Renal Physiology

Volumn 280, Issue 3 49-3, 2001, Pages

  Balster, Douglas A ^a   O'Dorisio, M Sue ^b   Summers, Monica A ^a   Turman, Martin A ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Immunohistochemistry; Mesangium; Renal; Reverse transcriptase polymerase chain reaction; Somatotropin release inhibitory factor

Indexed keywords

LECTIN; PROTEIN SST1; PROTEIN SST2; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR; TAMM HORSFALL GLYCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; FEMALE; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034986215     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2001.280.3.f457     Document Type: Article

References (41)

1. Growth factors and the mesangium
2. Somatostatin receptor gene expression in neuroblastoma
3. Effects of somatostatin on cultured human mesangial cells
4. Imaging of renal cell cancer with radiolabelled octreotide
5. Octreotide administration in diabetic rats: Effects on renal hypertrophy and urinary albumin excretion
6. Stimulation of hepatic insulin-like growth factor-binding protein-1 and -3 gene expression by octreotide in rats
7. Somatostatin antagonizes angiotensin II effects on mesangial cell contraction and glomerular filtration
8. Somatostatin activates particulate guanylate cyclase in cultured rat mesangial cells
9. Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes
10. Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth
11. Somatostatin analogs: Clinical application in relation to human somatostatin receptor subtypes
12. Effect of a somatostatin analogue (SMS 201-995) on renal function and urinary protein excretion in diabetic rats
13. Reversal of somatostatin inhibition of AVP-induced cAMP by pertussis toxin
14. Effect of long-acting somatostatin analog (Somatulin) on renal hyperfiltration in patients with IDDM
15. Distribution of somatostatin receptor type 3 in the rat: Immunohistochemical study
16. Distribution of somatostatin receptor type 2 in the rat: Immunohistochemical study
17. Distribution of somatostatin receptor type I in the rat. An immunohistochemical study
18. Variations in transcription-repair coupling in mouse cells
19. In vitro formation and expansion of cysts-derived from human renal cortex epithelial cells
20. Role of peptide radioimmunoassay in understanding peptide-peptide interactions and clinical expression of gastroenteropancreatic endocrine tumors
21. Somatostatin and its receptor family
22. Somatostatin as a modulator of distal nephron water permeability
23. Human kidney as target for somatostatin: High affinity receptors in tubules and vasa recta
24. Somatostatin receptors in human renal cell carcinomas
25. Expression and localization of somatostatin receptor sstR1, sstR 2, and sstR3 messenger RNAs in primary human tumors using in situ hybridization
26. Evidence for somatostatin binding sites in rabbit kidney
27. A dual effect of somatostatin on the proliferation of cultured rat mesangial cells
28. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes
29. Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat: Evidence for a direct and indirect mechanism of action
30. Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells
31. Molecular basis for somatostatin action: Inhibition of c-fos expression and AP-1 binding
32. Somatostatin inhibits AP-1 function via multiple protein phosphatases
33. Molecular mechanisms for somatostatin inhibition of c-fos gene expression
34. Effect of somatostatin on kidney function and vasoactive hormone systems in healthy subjects
35. Human proximal tubular epithelial cells express somatostatin: Regulation by growth factors and cAMP
36. Somatostatin inhibits epidermal growth factor-induced mitogenesis in human proximal tubular cells
37. Somatostatin expression in human renal cortex and mesangial cells
38. Effects of chronic administration of somatostatin analogue SMS 201-995 on the progression of chronic renal failure in subtotal nephrectomized rats
39. Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma
40. Effect of somatostatin on renal function
41. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney